| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/04/2002 | EP1235830A2 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 09/04/2002 | EP1235787A1 $g(b)2-ADRENERGIC RECEPTOR AGONISTS |
| 09/04/2002 | EP1235618A2 Bioconjugation in vivo to pulmonary or blood components |
| 09/04/2002 | EP1235597A2 Nucleic acid delivery system |
| 09/04/2002 | EP1235596A2 Use of lytic toxins and toxin conjugates |
| 09/04/2002 | EP1235595A2 Integrin-mediated drug targeting |
| 09/04/2002 | EP1235594A2 Inhibition of secretion from non-neuronal cells |
| 09/04/2002 | EP1235593A2 Hyperoncotic artificial cerebrospinal fluid and method of treating neural tissue edema therewith |
| 09/04/2002 | EP1235590A1 A method of treating a malignancy in a subject and a pharmaceutical composition for use in same |
| 09/04/2002 | EP1235586A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 09/04/2002 | EP1235585A2 Use of a milk protein hydrolysate in the treatment of diabetes |
| 09/04/2002 | EP1235584A2 Virus immunologic determinants |
| 09/04/2002 | EP1235488A1 Product and method for control of obesity |
| 09/04/2002 | EP1175390A4 Disodium salts, monohydrates, and ethanol solvates |
| 09/04/2002 | EP1068223B1 Calcium salts of lipopeptide antibiotics, method for producing same and their use |
| 09/04/2002 | EP1011700B1 An oral care composition comprising a bacillus pullulanase and a dextranase |
| 09/04/2002 | EP1009425B1 Use of Latency Associated Peptide for the manufacture of a medicament for increasing wound healing. |
| 09/04/2002 | EP0999849B1 Use of lbp in the treatment of septicaemia |
| 09/04/2002 | EP0991647B1 Eprosartan monohydrate |
| 09/04/2002 | EP0977583B1 Compositions comprising conjugates of stable, active, human ob protein with immunoglobulin fc chain and methods |
| 09/04/2002 | EP0949923B1 Stabilised pharmaceutical compositions, based on quinupristine and dalfopristine, and their preparation |
| 09/04/2002 | EP0941251B1 Use of an immunoglobulin preparation for producing an oral medicament preventing hemolytic uremic syndrome and preparation for the same |
| 09/04/2002 | EP0920447B1 Process of purification of cyclosporin |
| 09/04/2002 | EP0904095B1 Chimeric isoprenoid synthases and uses thereof |
| 09/04/2002 | EP0896615B1 Peptide from soluble form of acetylcholinesterase, active as a calcium channel modulator |
| 09/04/2002 | EP0832104B1 Dolastatin derivatives, their preparation and use |
| 09/04/2002 | EP0801574A4 Modulation of integrin-mediated signal transduction |
| 09/04/2002 | EP0781141B1 Aza cyclohexapeptide compounds |
| 09/04/2002 | EP0771209B1 Novel peptides |
| 09/04/2002 | EP0764208B1 Bmp-9 compositions |
| 09/04/2002 | EP0755443B1 Tissue-specific enhancer active in prostate |
| 09/04/2002 | EP0750515B1 Low molecular weight hyaluronic acid with peptide or protein |
| 09/04/2002 | EP0711355B1 Method for diagnosing a disorder by determining expression of gage tumor rejection antigen precursors |
| 09/04/2002 | EP0702723B1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 09/04/2002 | EP0682526B1 PULMONARY ADMINISTRATION OF THE SOLUBLE COMPLEM RECEPTOR TYPE 1 sCR1 |
| 09/04/2002 | EP0590006B1 Synthetic pulmonary surfactant peptides |
| 09/04/2002 | EP0205475B2 Recombinant methods for production of serine protease inhibitors and dna sequences useful for same |
| 09/04/2002 | CN1367875A Induction method of TH1-like response in vitro |
| 09/04/2002 | CN1367832A Ehrlichia canis genes and vaccines |
| 09/04/2002 | CN1367830A Cancer associated antigens and uses therefor |
| 09/04/2002 | CN1367829A Compositions and methods for therapy and diagnosis of lung cancer |
| 09/04/2002 | CN1367828A Oligonucleotides for inhibiting expression of human eg5 |
| 09/04/2002 | CN1367826A Method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 09/04/2002 | CN1367793A Neuromedin B and somatostatin receptor agonists |
| 09/04/2002 | CN1367792A Somatostatin agonists |
| 09/04/2002 | CN1367791A Novel angiogenesis inhibitor |
| 09/04/2002 | CN1367704A Agent for gene therapy and for prevention of metastases, as well as for gene therapy of tumors |
| 09/04/2002 | CN1367703A Freeze dried HGF preparations |
| 09/04/2002 | CN1367702A Renal cell carcinoma treatment |
| 09/04/2002 | CN1367701A Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 09/04/2002 | CN1367700A Small peptides and method for downregulation of lgE |
| 09/04/2002 | CN1367691A New use of taxoid derivatives |
| 09/04/2002 | CN1367688A Compositions containing immunotoxins and agents that inhibit dendritic cell maturation for inducing immune tolerance to graft |
| 09/04/2002 | CN1367686A Novel compositions |
| 09/04/2002 | CN1367676A Preserving hemoglobin blood substitute with transparent overwrap |
| 09/04/2002 | CN1367653A Combined use of triglycerides containing medium chain fatty acids and exogenous lipolytic enzymes as feed supplements |
| 09/04/2002 | CN1367248A Novel tumor wilting matter 2 ligand gene, its expressed tumor wilting matter and its preparation method |
| 09/04/2002 | CN1367247A Heavy metal toxinicide, its preparation method and application |
| 09/04/2002 | CN1367180A Novel natural antibacterial peptide, its code sequence and application |
| 09/04/2002 | CN1367179A Novel liver regeneration related protein, its code sequence and application |
| 09/04/2002 | CN1367177A Antibactrial polypeptide separated from biological living body |
| 09/04/2002 | CN1367176A Novel recombinant human tissue factor pathway inhibitor active peptide and its preparation method |
| 09/04/2002 | CN1367019A Thrombase capable of carrying about and its preparation method |
| 09/04/2002 | CN1367018A Compound preparation of staphylococcolysis enzyme and its preparation method and application |
| 09/04/2002 | CN1367017A Application of transitional scorpion toxin BmK abT |
| 09/04/2002 | CN1366991A Application of plant extract for preparing medicine to cure bone absorption increment diseases |
| 09/04/2002 | CN1366874A Personal nursing compound |
| 09/04/2002 | CN1090031C Novel use of ACE-inhibitor for treatment of dyspeptic symptoms |
| 09/04/2002 | CN1090030C Complex cow's milk gamma globulin and making method thereof |
| 09/04/2002 | CN1090029C Combinations of thrombolytically active proteins and anticoagulants, and uses thereof |
| 09/04/2002 | CN1090028C Medicine for treatment of restenosis and arteriosclerosis |
| 09/04/2002 | CN1090027C Immunity-strengthening and infection-preventing medicine |
| 09/03/2002 | US6444873 MSH5 ablated mice and uses therefor |
| 09/03/2002 | US6444817 Anticoagulants |
| 09/03/2002 | US6444811 Central nervous system disorders; cardiovascular disorders |
| 09/03/2002 | US6444803 Bone mineralization proteins, DNA, vectors, expression systems |
| 09/03/2002 | US6444802 Human aminopeptidase |
| 09/03/2002 | US6444800 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 09/03/2002 | US6444799 P. gingivalis polynucleotides and uses thereof |
| 09/03/2002 | US6444793 Hydrophobically-modified hedgehog protein compositions and methods |
| 09/03/2002 | US6444792 CTLA4-Cγ4 fusion proteins |
| 09/03/2002 | US6444791 Therapy for vision defects; administering macroglobulins |
| 09/03/2002 | US6444790 Peptidoglycan recognition proteins |
| 09/03/2002 | US6444789 CD16-II variants |
| 09/03/2002 | US6444786 Bactericides |
| 09/03/2002 | US6444699 Method for treatment of aging or damage skin |
| 09/03/2002 | US6444678 α- and β-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 09/03/2002 | US6444672 Heterocyclic derivatives and their use as antithrombotic agents |
| 09/03/2002 | US6444663 Treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, and for the prevention of ischemic injury. |
| 09/03/2002 | US6444655 Galactopyranosides and their use |
| 09/03/2002 | US6444650 Antisense compositions for detecting and inhibiting telomerase reverse transcriptase |
| 09/03/2002 | US6444647 Composition comprising safe and effective amounts of vitamin b3 compound and additional skin care active selected from farnesol and/or phytantriol, and dermatologically acceptable emulsion carrier |
| 09/03/2002 | US6444646 Use of angiotensin II type 2 receptor agonists in tissue repair |
| 09/03/2002 | US6444645 Crosslink-stabilized indolicidin analogs |
| 09/03/2002 | US6444644 Peptide having specified amino acid sequence; used for inhibition of thromboplastin |
| 09/03/2002 | US6444643 Methods of using inhibitors of cyclophilin rotamase activity to affect neurological activity |
| 09/03/2002 | US6444642 Administering to mammal effective amount of neuregulin polypeptide with p185.sup.erbb2 protein binding activity to stimulate myogenesis of muscle cells |
| 09/03/2002 | US6444641 Fatty acid-acylated insulin analogs |
| 09/03/2002 | US6444640 Composition useful in treating condition, comprising trail molecule and dna damaging agent sufficient to affect apoptosis |
| 09/03/2002 | US6444639 Human chorionic gonadotrophin (hcg) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |